DE69638196D1 - Rekombinantes sendai-virus - Google Patents

Rekombinantes sendai-virus

Info

Publication number
DE69638196D1
DE69638196D1 DE69638196T DE69638196T DE69638196D1 DE 69638196 D1 DE69638196 D1 DE 69638196D1 DE 69638196 T DE69638196 T DE 69638196T DE 69638196 T DE69638196 T DE 69638196T DE 69638196 D1 DE69638196 D1 DE 69638196D1
Authority
DE
Germany
Prior art keywords
sendai virus
recombinant sendai
virus
transfecting
regenerating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69638196T
Other languages
English (en)
Inventor
Yoshiyuki Nagai
Atsushi Kato
Fukashi Murai
Tsuneaki Sakata
Mamoru Hasegawa
Tatsuo Shioda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dnavec Research Inc
Original Assignee
Dnavec Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dnavec Research Inc filed Critical Dnavec Research Inc
Application granted granted Critical
Publication of DE69638196D1 publication Critical patent/DE69638196D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18811—Sendai virus
    • C12N2760/18841—Use of virus, viral particle or viral elements as a vector
    • C12N2760/18843—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18811—Sendai virus
    • C12N2760/18851—Methods of production or purification of viral material
    • C12N2760/18852—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69638196T 1995-11-01 1996-10-22 Rekombinantes sendai-virus Expired - Lifetime DE69638196D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP28541795 1995-11-01
PCT/JP1996/003069 WO1997016539A1 (fr) 1995-11-01 1996-10-22 Virus sendai recombinant

Publications (1)

Publication Number Publication Date
DE69638196D1 true DE69638196D1 (de) 2010-07-22

Family

ID=17691258

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69638196T Expired - Lifetime DE69638196D1 (de) 1995-11-01 1996-10-22 Rekombinantes sendai-virus

Country Status (11)

Country Link
US (2) US7101685B2 (de)
EP (1) EP0863202B1 (de)
KR (1) KR100525687B1 (de)
CN (1) CN1143892C (de)
AT (1) ATE470704T1 (de)
AU (1) AU7335296A (de)
CA (1) CA2236378C (de)
DE (1) DE69638196D1 (de)
DK (1) DK0863202T3 (de)
HK (1) HK1018078A1 (de)
WO (1) WO1997016539A1 (de)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100525687B1 (ko) * 1995-11-01 2005-11-25 가부시끼가이샤 디나벡 겡뀨쇼 재조합체 센다이바이러스
CN1129530C (zh) * 1998-05-18 2003-12-03 精工爱普生株式会社 喷墨打印设备
US7241617B2 (en) 1998-07-03 2007-07-10 Dnavec Research, Inc. Sendai viral vectors comprising foreign genes inserted between the R1 and R2 Loci
ATE430806T1 (de) * 1998-07-03 2009-05-15 Dnavec Research Inc (-)-strang rns virusvektor für nervenzellen
US6828138B1 (en) * 1998-08-11 2004-12-07 Dnavec Research Inc. Recombinant sendai virus vector including a gene encoding a chemokine
US6544785B1 (en) 1998-09-14 2003-04-08 Mount Sinai School Of Medicine Of New York University Helper-free rescue of recombinant negative strand RNA viruses
DE69933528T2 (de) * 1998-11-09 2007-08-09 Nippon Biologicals, Inc. Verfahren zur Cytokinproduktionn unter Verwendung eines Sendai Virus Expressionssystems
US6490775B1 (en) * 1999-04-23 2002-12-10 Veri-Tek Inc. Press operation verification system
US7226786B2 (en) 1999-05-18 2007-06-05 Dnavec Research Inc. Envelope gene-deficient Paramyxovirus vector
DE60035589T2 (de) * 1999-05-18 2008-04-17 Dnavec Research Inc., Tsukuba Viraler paramyxoviridae vektor mit einem defekten hüllprotein-gen
US20030166252A1 (en) * 1999-05-18 2003-09-04 Kaio Kitazato Paramyxovirus-derived RNP
EP1211318B1 (de) 1999-09-06 2007-08-08 DNAVEC Research, Inc. Paramyxoviren, die eine modifizierte transkriptionsstartsequenz umfassen
KR100772276B1 (ko) 1999-11-02 2007-11-01 가부시키가이샤 디나벡크 겐큐쇼 기도 상피로의 외인성 유전자 도입용 재조합센다이바이러스 벡터
JP4838962B2 (ja) * 1999-11-02 2011-12-14 株式会社ディナベック研究所 気道上皮細胞への外因性遺伝子導入用組換えセンダイウイルスベクター
US7314614B1 (en) 1999-11-02 2008-01-01 Dnavec Research, Inc. Recombinant sendai virus vector for introducing exogenous genes to airway epithelia
CA2397903A1 (en) * 2000-01-19 2001-07-26 Dnavec Research Inc. Use of paramyxovirus vector for gene transfer into blood vessel
EP1270016A4 (de) 2000-03-30 2005-10-19 Dnavec Research Inc Aidsvirus-impfstoff unter verwendung eines sendaivirus-vektors
JP2001275684A (ja) * 2000-03-31 2001-10-09 Nippon Medical Research Kk 組換え体イヌジステンパーウイルスおよびその作製方法
CA2322057A1 (en) 2000-05-18 2001-11-18 Dnavec Research Inc. Paramyxovirus vectors used for transfer of foreign genes
AU2001264824A1 (en) * 2000-06-01 2001-12-11 St. Jude Children's Research Hospital Vaccine and gene therapy vector and methods of use thereof
CN100531802C (zh) * 2000-06-01 2009-08-26 株式会社载体研究所 含有血凝素活性膜蛋白质的假型逆转录病毒载体
WO2002000264A1 (fr) * 2000-06-27 2002-01-03 Dnavec Research Inc. Vecteur de virus pour transfert de gene dans des cellules renales
CN1526014A (zh) * 2000-10-06 2004-09-01 ��ʽ���������о��� 用于将外源基因导入骨骼肌的副粘病毒载体
JP2002142770A (ja) * 2000-11-08 2002-05-21 Dnavec Research Inc 循環系への遺伝子送達用パラミクソウイルスベクター
AU2002224113A1 (en) 2000-11-27 2002-06-03 Dnavec Research Inc. Paramyxovirus vector encoding angiogenesis gene and utilization thereof
US6596206B2 (en) * 2001-03-30 2003-07-22 Picoliter Inc. Generation of pharmaceutical agent particles using focused acoustic energy
US7465456B2 (en) 2002-04-26 2008-12-16 Medimmune, Llc Multi plasmid system for the production of influenza virus
AU2003231083A1 (en) 2002-04-26 2003-11-10 Medimmune, Llc Multi plasmid system for the production of influenza virus
WO2003092738A1 (fr) * 2002-04-30 2003-11-13 Dnavec Research Inc. Composition support de medicament ou de gene avec activite d'hemagglutinine
WO2003102183A1 (fr) * 2002-06-03 2003-12-11 Dnavec Research Inc. Vecteurs de paramyxovirus codant pour un anticorps et son utilisation
AU2003261931A1 (en) * 2002-09-04 2004-03-29 Dnavec Research Inc. Process for producing virus vector containing membrane protein having sialic acid-binding activitiy in envelope with the use of gram-positive bacterium-origin neuraminidase
JPWO2004038029A1 (ja) * 2002-10-24 2006-02-23 株式会社ディナベック研究所 Ｔ細胞に遺伝子を導入する方法
WO2005018539A2 (en) 2003-06-16 2005-03-03 Medimmune Vaccines, Inc. Influenza hemagglutinin and neuraminidase variants
JPWO2005001082A1 (ja) * 2003-06-30 2006-08-10 株式会社ディナベック研究所 高変異領域が改変された遺伝子を搭載するマイナス鎖ｒｎａウイルスベクター
CA2544786A1 (en) * 2003-11-04 2005-05-12 Dnavec Research Inc. Method for producing gene transferred dendritic cells
DE602004027537D1 (de) 2003-12-23 2010-07-15 Medimmune Inc
CN1929867A (zh) 2004-01-13 2007-03-14 株式会社载体研究所 肿瘤的基因治疗，即利用编码免疫刺激性细胞因子的单链负链rna病毒载体进行的治疗
CN1934260B (zh) 2004-01-22 2013-03-13 株式会社载体研究所 利用含有巨细胞病毒增强子和鸡β-肌动蛋白启动子的杂合启动子制造负链RNA病毒载体的方法
WO2005071085A1 (ja) * 2004-01-22 2005-08-04 Dnavec Research Inc. ウイルスベクターの製造方法
JPWO2005087269A1 (ja) * 2004-03-16 2008-01-24 株式会社ディナベック研究所 腫瘍増殖を抑制する方法
US20080038234A1 (en) * 2004-03-23 2008-02-14 Shuji Hayashi Bone Marrow-Related Cells Associated With Tissue Maintenance And/Or Repair
CA2822895A1 (en) 2004-05-25 2005-12-08 Medimmune, Llc Influenza hemagglutinin and neuraminidase variants
CN101006172B (zh) 2004-06-24 2012-09-05 株式会社载体研究所 包含导入了rna病毒的树突状细胞的抗癌剂
DE102005006388A1 (de) * 2005-02-11 2006-08-24 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Replikationsdefiziente RNA-Viren als Impfstoffe
ES2527503T3 (es) 2005-03-08 2015-01-26 Medimmune, Llc Virus influenza reordenantes
WO2006134917A1 (ja) 2005-06-14 2006-12-21 Dnavec Corporation 抗体の作製方法
EP2993235B1 (de) 2005-10-28 2019-02-13 ID Pharma Co., Ltd. Gentransfer in epithelialen stammzellen der atemwege unter verwendung von similian lentiviralen vektoren mit senadai rna-virus-spikeprotein pseudotypisierten vektoren
US20100167341A1 (en) * 2006-01-17 2010-07-01 Dnavec Corporation Novel protein expression system
JPWO2007139178A1 (ja) 2006-05-31 2009-10-15 ディナベック株式会社 アルツハイマー病治療薬
EP2048232A4 (de) * 2006-07-13 2010-10-13 Dnavec Corp Nichtreplizierender paramyxoviridae-virusvektor
WO2008133701A1 (en) 2006-07-21 2008-11-06 Medimmune, Llc. Methods and compositions for increasing replication capacity of an influenza virus
CN104278014A (zh) 2006-08-09 2015-01-14 米迪缪尼有限公司 流感血凝素和神经氨酸酶变体
US20110021600A1 (en) 2006-09-04 2011-01-27 Kyowa Hakko Kirin Co., Ltd. Novel nucleic acid
WO2008100292A2 (en) 2006-10-16 2008-08-21 Genelux Corporation Modified vaccinia virus strains for use in diagnostic and therapeutic methods
JPWO2008084319A1 (ja) 2006-12-18 2010-04-30 協和発酵キリン株式会社 新規核酸
US20100323428A1 (en) 2007-02-07 2010-12-23 Dnavec Corporation Attenuated minus-stranded rna virus
US9145564B2 (en) * 2007-04-13 2015-09-29 National Institute Of Advanced Industrial Science And Technology Persistently infective Sendai virus vector
EP2143794A1 (de) 2007-04-27 2010-01-13 Kyushu University, National University Corporation Viraler vektor für gentherapie
EP2674486A1 (de) 2007-06-18 2013-12-18 MedImmune, LLC Influenza-B-Viren mit Veränderungen im Hämagglutininpolypeptid
WO2009044899A1 (ja) 2007-10-03 2009-04-09 Kyowa Hakko Kirin Co., Ltd. 細胞の増殖を制御する核酸
WO2009148137A1 (ja) 2008-06-04 2009-12-10 協和発酵キリン株式会社 肥満細胞の脱顆粒を制御する核酸
CA2730408A1 (en) 2008-07-11 2010-01-14 Chin-Fen Yang Influenza hemagglutinin and neuraminidase variants
EP3075850B1 (de) 2008-07-16 2019-02-06 ID Pharma Co., Ltd. Verfahren zur herstellung einer neuprogrammierten zelle anhand eines chromosomal unintegrierten virusvektors
CN102272302B (zh) 2008-10-31 2015-04-15 生物载体株式会社 增强重组蛋白表达的方法
EP2396033B1 (de) 2009-02-12 2016-09-28 MedImmune, LLC Influenza-hämagglutinin- und neuraminidase-varianten
JP2009268471A (ja) * 2009-08-07 2009-11-19 Dnavec Research Inc センダイウイルスベクターを用いたワクチンおよびワクチンタンパク質
CN102711812B (zh) 2010-01-08 2014-07-16 国立大学法人京都大学 Tau蛋白病治疗用疫苗
EP2612911B1 (de) 2010-08-30 2018-01-17 ID Pharma Co., Ltd. Zusammensetzung zur induktion pluripotenter stammzellen und ihre verwendung
CN102205118B (zh) * 2011-03-25 2013-05-22 天津济命生生物科技有限公司 一种生物制品及其制备方法
US9637758B2 (en) 2011-04-28 2017-05-02 St. Jude Children's Research Hospital Modified Sendai virus vaccine and imaging vector
US9951349B2 (en) * 2011-09-27 2018-04-24 Yale University Compositions and methods for transient expression of recombinant RNA
RU2519763C9 (ru) * 2012-11-26 2015-04-27 Ольга Вячеславовна Матвеева Метод иммунотерапии онкологических заболеваний и фармацевтические композиции на основе онколитического вируса сендай
US10975358B2 (en) 2013-09-24 2021-04-13 Id Pharma Co., Ltd. Method for improving efficiency of inducing pluripotent stem cell
JP7150241B2 (ja) 2016-11-17 2022-10-11 国立感染症研究所長 非感染性パラミクソウイルス粒子を用いた感染症ワクチン
CA3070552A1 (en) 2017-07-21 2019-01-24 I'rom Group Co., Ltd. Polynucleotide for modifying target sequence and use thereof
US20200353070A1 (en) 2018-01-22 2020-11-12 Japan As Represented By The Director-General Of National Institute Of Infectious Diseases Selective cd8-positive t cell-inducing vaccine antigen
CN112538498B (zh) * 2020-04-20 2023-04-25 梅尔顿(深圳)生物医药技术有限公司 重组仙台病毒的构建方法及其应用
WO2022050419A1 (ja) 2020-09-04 2022-03-10 Ｈｅａｒｔｓｅｅｄ株式会社 ｉＰＳ細胞の品質改善剤、ｉＰＳ細胞の製造方法、ｉＰＳ細胞、及びｉＰＳ細胞製造用組成物
AU2021409196A1 (en) 2020-12-25 2023-08-03 Id Pharma Co., Ltd. Method for producing naive human ips cells from somatic cells
WO2023227758A1 (en) 2022-05-25 2023-11-30 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Vaccine with reduced anti-vector antigenicity

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217879A (en) * 1989-01-12 1993-06-08 Washington University Infectious Sindbis virus vectors
US5166057A (en) * 1989-08-28 1992-11-24 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant negative strand rna virus expression-systems
AU7007491A (en) 1990-02-02 1991-08-08 Schweiz. Serum- & Impfinstitut Bern Cdna corresponding to the genome of negative-strand rna viruses, and process for the production of infectious negative-strand rna viruses
JP3029272B2 (ja) * 1990-05-29 2000-04-04 邦忠 下遠野 構造蛋白質遺伝子、組換えベクター、組換えウイルス、ポリペプチドおよびポリペプチドの製造方法
US5665362A (en) * 1990-09-25 1997-09-09 Cantab Pharmaceuticals Research Limited Viral vaccines
US5173414A (en) * 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
US5318898A (en) 1991-04-02 1994-06-07 Genetics Institute, Inc. Production of recombinant bone-inducing proteins
JPH0585943A (ja) * 1991-07-18 1993-04-06 Tonen Corp 組換えワクシニアウイルスを用いる非ａ非ｂ型肝炎ウイルス遺伝子の発現および非ａ非ｂ型肝炎ワクチン
US5445953A (en) * 1991-08-26 1995-08-29 Immuno Aktiengesellschaft Direct molecular cloning of a modified poxvirus genome
JPH05301895A (ja) * 1992-04-22 1993-11-16 Nippon Zeon Co Ltd ハイブリッド抗原タンパク質、それを発現する組み換えウイルス、及びその製造方法
ZA937164B (en) 1992-09-28 1994-05-23 Commw Scient Ind Res Org Delivery system
DE69532369T3 (de) * 1994-07-18 2010-11-04 Conzelmann, Karl-Klaus, Prof. Dr. Rekombinantes infektiöses nicht-in-Segmente-geteiltes, negativ-Strange-RNS-Virus
US5716821A (en) * 1994-09-30 1998-02-10 Uab Research Foundation Prevention and treatment of respiratory tract disease
WO1996010400A1 (en) 1994-09-30 1996-04-11 The Uab Research Foundation Gene therapy vectors and vaccines based on non-segmented negatives stranded rna viruses
DE69510207T3 (de) 1995-08-09 2007-02-15 Schweiz. Serum- & Impfinstitut Bern Verfahren zur Herstellung von infektiösen minussträngigen RNA-Viren
DK0864645T3 (da) * 1995-10-31 2005-10-24 Dnavec Research Inc Negativstrenget RNA-virusvektor med autonom replikeringsaktivitet
KR100525687B1 (ko) * 1995-11-01 2005-11-25 가부시끼가이샤 디나벡 겡뀨쇼 재조합체 센다이바이러스
WO1997041245A1 (en) 1996-05-01 1997-11-06 The Government Of The United States Of America, Represented By The Secretary Of The Department Of Health And Human Services Generation of viral transfectants using recombinant dna-derived nucleocapsid proteins
AT405939B (de) 1997-02-24 1999-12-27 Immuno Ag Verfahren zur inaktivierung von lipidumhüllten viren
US6231868B1 (en) * 1997-09-30 2001-05-15 University Of Maryland-Biotechnology Institute Method for generating nonpathogenic infections birnavirus from synthetic RNA transcripts
US7241617B2 (en) 1998-07-03 2007-07-10 Dnavec Research, Inc. Sendai viral vectors comprising foreign genes inserted between the R1 and R2 Loci
US6828138B1 (en) 1998-08-11 2004-12-07 Dnavec Research Inc. Recombinant sendai virus vector including a gene encoding a chemokine
DE69933528T2 (de) * 1998-11-09 2007-08-09 Nippon Biologicals, Inc. Verfahren zur Cytokinproduktionn unter Verwendung eines Sendai Virus Expressionssystems
US20030166252A1 (en) 1999-05-18 2003-09-04 Kaio Kitazato Paramyxovirus-derived RNP
US7226786B2 (en) 1999-05-18 2007-06-05 Dnavec Research Inc. Envelope gene-deficient Paramyxovirus vector
CA2397903A1 (en) 2000-01-19 2001-07-26 Dnavec Research Inc. Use of paramyxovirus vector for gene transfer into blood vessel
EP1270016A4 (de) 2000-03-30 2005-10-19 Dnavec Research Inc Aidsvirus-impfstoff unter verwendung eines sendaivirus-vektors
CA2322057A1 (en) * 2000-05-18 2001-11-18 Dnavec Research Inc. Paramyxovirus vectors used for transfer of foreign genes
WO2002000264A1 (fr) 2000-06-27 2002-01-03 Dnavec Research Inc. Vecteur de virus pour transfert de gene dans des cellules renales
CN1526014A (zh) 2000-10-06 2004-09-01 ��ʽ���������о��� 用于将外源基因导入骨骼肌的副粘病毒载体
AU2002224113A1 (en) 2000-11-27 2002-06-03 Dnavec Research Inc. Paramyxovirus vector encoding angiogenesis gene and utilization thereof
JPWO2004038029A1 (ja) 2002-10-24 2006-02-23 株式会社ディナベック研究所 Ｔ細胞に遺伝子を導入する方法
CA2514937A1 (en) 2003-01-31 2004-08-12 Dnavec Research Inc. Paramyxoviral vectors encoding ribozymes and uses thereof
JPWO2005001082A1 (ja) 2003-06-30 2006-08-10 株式会社ディナベック研究所 高変異領域が改変された遺伝子を搭載するマイナス鎖ｒｎａウイルスベクター
CA2544786A1 (en) 2003-11-04 2005-05-12 Dnavec Research Inc. Method for producing gene transferred dendritic cells
CN1929867A (zh) 2004-01-13 2007-03-14 株式会社载体研究所 肿瘤的基因治疗，即利用编码免疫刺激性细胞因子的单链负链rna病毒载体进行的治疗
CN1934260B (zh) 2004-01-22 2013-03-13 株式会社载体研究所 利用含有巨细胞病毒增强子和鸡β-肌动蛋白启动子的杂合启动子制造负链RNA病毒载体的方法
WO2005071085A1 (ja) 2004-01-22 2005-08-04 Dnavec Research Inc. ウイルスベクターの製造方法
US20080038234A1 (en) 2004-03-23 2008-02-14 Shuji Hayashi Bone Marrow-Related Cells Associated With Tissue Maintenance And/Or Repair
CN101006172B (zh) 2004-06-24 2012-09-05 株式会社载体研究所 包含导入了rna病毒的树突状细胞的抗癌剂

Also Published As

Publication number Publication date
KR100525687B1 (ko) 2005-11-25
CN1207124A (zh) 1999-02-03
EP0863202A4 (de) 1999-03-03
KR19990067271A (ko) 1999-08-16
DK0863202T3 (da) 2010-09-27
US7442544B2 (en) 2008-10-28
EP0863202B1 (de) 2010-06-09
CA2236378C (en) 2011-01-25
US20020098576A1 (en) 2002-07-25
CA2236378A1 (en) 1997-05-09
CN1143892C (zh) 2004-03-31
EP0863202A1 (de) 1998-09-09
AU7335296A (en) 1997-05-22
US20050266566A1 (en) 2005-12-01
WO1997016539A1 (fr) 1997-05-09
ATE470704T1 (de) 2010-06-15
HK1018078A1 (en) 1999-12-10
US7101685B2 (en) 2006-09-05

Similar Documents

Publication Publication Date Title
DE69638196D1 (de) Rekombinantes sendai-virus
DE69634904D1 (de) Negativstrand rna virus mit selbständiger replikationsaktivität
PT836648E (pt) Virus mva recombinante e sua utilizacao
PL333070A1 (en) Infectious clones of rna viruses and vaccines based on them
DE69637723D1 (de) Rekombinantes,virales vektorsystem
DK0787200T3 (da) Forbedret adenovirus og fremgangsmåder til anvendelse heraf
ATE423203T1 (de) Rekombinantes virales vektorsystem
ATE358732T1 (de) Anti-virale vektoren
CA2104396A1 (en) Viral particles having altered host range
BR9711998A (pt) Herpesvìrus saimiri como vetor viral.
WO1994013812A3 (en) Novel entomopoxvirus genes, proteins and methods of use thereof
DE69324645D1 (de) Verfahren zur Herstellung von Hepatitis Antigenen und Impfstoffen
WO2003025187A8 (en) Improvement of gene expression in vectors
DE69839269D1 (de) Infektiöse vektoren und pflanzenklone, die sich von turnip mosaikvirus herleiten
WO2002083896A3 (en) Recombinant segmented negative strand virus with a duplicated 3' noncoding flanking sequence, and therapeutic compositions containing the same
DK0915165T3 (da) Fremgangsmåde til hjælper-virusfri pakning af et genvektor-DNA
FI98466B (fi) FSME-viruksen läntisen alatyypin eristettyjä DNA- ja RNA-molekyylejä, näitä sisältäviä vektoreita ja soluviljelmiä sekä menetelmä näiden koodittamien peptidien valmistamiseksi